NCT02238223View on ClinicalTrials.gov

Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

CompletedOBSERVATIONAL
Enrollment

2,001

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2006

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Alesion®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY